Sensorion (France) Performance
| ALSEN Stock | EUR 0.69 0.05 7.81% |
Sensorion has a performance score of 1 on a scale of 0 to 100. The entity has a beta of 0.0128, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Sensorion's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sensorion is expected to be smaller as well. Sensorion SA right now has a risk of 3.23%. Please validate Sensorion sortino ratio and the relationship between the downside variance and market facilitation index , to decide if Sensorion will be following its existing price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Sensorion SA are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Sensorion is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Begin Period Cash Flow | 62.2 M | |
| Total Cashflows From Investing Activities | -1.1 M |
Sensorion |
Sensorion Relative Risk vs. Return Landscape
If you would invest 69.00 in Sensorion SA on September 3, 2024 and sell it today you would earn a total of 0.00 from holding Sensorion SA or generate 0.0% return on investment over 90 days. Sensorion SA is generating 0.0508% of daily returns and assumes 3.2332% volatility on return distribution over the 90 days horizon. Simply put, 28% of stocks are less volatile than Sensorion, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Sensorion Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sensorion's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sensorion SA, and traders can use it to determine the average amount a Sensorion's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0157
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | ALSEN | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.23 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Sensorion is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sensorion by adding it to a well-diversified portfolio.
Sensorion Fundamentals Growth
Sensorion Stock prices reflect investors' perceptions of the future prospects and financial health of Sensorion, and Sensorion fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sensorion Stock performance.
| Return On Equity | -0.5 | |||
| Return On Asset | -0.24 | |||
| Operating Margin | (4.64) % | |||
| Current Valuation | (3.6 M) | |||
| Shares Outstanding | 79.94 M | |||
| Price To Earning | (4.37) X | |||
| Price To Book | 0.97 X | |||
| Price To Sales | 6.58 X | |||
| Revenue | 3.34 M | |||
| EBITDA | (14.64 M) | |||
| Cash And Equivalents | 38.03 M | |||
| Cash Per Share | 0.21 X | |||
| Total Debt | 3.36 M | |||
| Debt To Equity | 0.09 % | |||
| Book Value Per Share | 0.55 X | |||
| Cash Flow From Operations | (10.77 M) | |||
| Earnings Per Share | (0.29) X | |||
| Total Asset | 59.09 M | |||
| Retained Earnings | (11 M) | |||
| Current Asset | 15 M | |||
| Current Liabilities | 1000 K | |||
About Sensorion Performance
Assessing Sensorion's fundamental ratios provides investors with valuable insights into Sensorion's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Sensorion is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Sensorion SA, a clinical-stage biopharmaceutical company, develops therapies for the treatment of inner ear disorders in France. The company was founded in 2009 and is headquartered in Montpellier, France. SENSORION operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 33 people.Things to note about Sensorion SA performance evaluation
Checking the ongoing alerts about Sensorion for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sensorion SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sensorion SA has some characteristics of a very speculative penny stock | |
| Sensorion SA had very high historical volatility over the last 90 days | |
| The company reported the revenue of 3.34 M. Net Loss for the year was (15.14 M) with profit before overhead, payroll, taxes, and interest of 4.26 M. | |
| Sensorion SA has accumulated about 38.03 M in cash with (10.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.21. | |
| Roughly 49.0% of the company shares are held by company insiders |
- Analyzing Sensorion's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sensorion's stock is overvalued or undervalued compared to its peers.
- Examining Sensorion's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sensorion's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sensorion's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sensorion's stock. These opinions can provide insight into Sensorion's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Sensorion Stock Analysis
When running Sensorion's price analysis, check to measure Sensorion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sensorion is operating at the current time. Most of Sensorion's value examination focuses on studying past and present price action to predict the probability of Sensorion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sensorion's price. Additionally, you may evaluate how the addition of Sensorion to your portfolios can decrease your overall portfolio volatility.